FDA Inspection
ImprimisRx CA, Inc., dba ImprimisRxImprimisRx CA, Inc., dba ImprimisRx – FDA Inspection, Mar 14, 2016
Record Details
This FDA Inspection record concerns ImprimisRx CA, Inc., dba ImprimisRx, with an inspection on March 14, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 14, 2016
- Product Type
- Drugs
View Company Profile
ID · 9b577143-3469-4f01-8b62-07a123ec609a
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 962695
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
8- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
- 21 CFR 211.28(a)Clothing appropriate for duties performed
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.80(b)Handling and Storage to Prevent Contamination
Full citation text and observation details available on the Dashboard.
Other FDA inspections of ImprimisRx CA, Inc., dba ImprimisRx
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 31, 2017 | Not classified | Los Angeles District Office | Drug Quality Assurance |
Other documents for ImprimisRx CA, Inc., dba ImprimisRx
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.